Skip to content

Clinical Use of Vancomycin in Pediatric Patients: A Real World Study

Clinical Use of Vancomycin in Pediatric Patients: A Real World Study

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022308
Enrollment
Unknown
Registered
2019-04-04
Start date
2019-04-15
Completion date
Unknown
Last updated
2019-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious Diseases

Interventions

Sponsors

Children’s Hospital Affiliated to Zhengzhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Aged 0-18 years; 2. Patients who received intravenous vancomycin infusion for more than 3 days; 3. Patients who had more than 1 TDM results;

Exclusion criteria

Exclusion criteria: 1. Patients with a therapeutic history of vancomycin; 2. Vancomycin TDM results were not steady trough concentration;

Design outcomes

Primary

MeasureTime frame
the rate of vancomycin trough concentrations within the desired target range;adverse events;

Countries

China

Contacts

Public ContactLv Meng

Children’s Hospital Affiliated to Zhengzhou

lvmengyh@126.com+86 15136114537

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026